NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmphenol ( APH) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $65 price target. Berkshire Hathaway (A shares) ( BRK.A) downgraded to hold at TheStreet Ratings. Berkshire Hathaway (B shares) ( BRK.B) downgraded to hold at TheStreet Ratings. Freescale Semi ( FSL) rated new Neutral at UBS. $11.75 price target. Limited near term catalysts as turnaround in progress. Globus Medical ( GMED) rated new Buy at Goldman. $18 price target. Company can deliver 13% annual sales growth and is reasonably valued. Globus Medical rated new Outperform at Oppenheimer. $18 price target. Company is growing faster than its peers and expanding internationally. GlaxoSmithKline ( GSK) downgraded at UBS to Neutral from Buy, UBS said. $48.18 price target. Valuation, earnings visibility limit potential for further upside. KLA-Tencor ( KLAC) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $44 price target. Company is leveraged to lower foundry spending. Pioneer Southwest ( PSE) downgraded at UBS to Sell from Neutral, UBS said. $24 price target. Limited hedge book relative to peers.
STOCK COMMENTS / EPS CHANGES
Gilead ( GILD) estimates, target increased at Jefferies. GILD estimates were raised through 2013, Jefferies said. Stribild quad pill was approved with the FDA and the company announced higher pricing. Hold rating and new $55 price target. Ingersoll-Rand ( IR) target raised at UBS to $54, UBS said. Several potential catalysts including improving HVAC business conditions. Buy rating. M&T Bank ( MTB) numbers boosted at Credit Suisse. Shares of MTB now seen reaching $102, according to Credit Suisse. Estimates also upped, as the HCBK acquisition should add to earnings. Neutral rating. PVH ( PVH) estimates, target raised at Brean. Shares of PVH now seen reaching $115, according to Brean Murray. Estimates also increased, as the company is seeing better growth across the board. Buy rating. Rackspace ( RAX) target boosted at JMP. Shares of RAX now seen reaching $65, according to JMP Securities. Company can continue to grow through its potential inclusion in the OpenStack Foundation. Outperform rating. VMWare ( VMW) target raised at ThinkEquity to $105. Company can create a true enterprise datacenter destination. Buy rating. >To submit a news tip, email: email@example.com.